Jennifer Brodbelt, professor of chemistry and biochemistry, has received a $734,068 grant from the National Institutes of Health to develop a new method for rapidly screening blood samples for biomarkers. Biomarkers are small molecules that indicate the presence of a particular physiological condition, typically a disease. The new method, if successful, could prove useful not just for identifying markers of specific diseases such as cancer or heart disease, but for discovering broader metabolic patterns correlated with conditions such as aging or obesity.
Prof gets grant to develop better technology for blood screening
Marjorie Smith | Nov. 9, 2009